| Adjuvant therapy of osteosarcoma |
| JR Bertino |
|
JCO Jun 1 1987: 831–832.
[PDF]
|
 |
| Grade 3 nausea, vomiting, and myelosuppression or progressive, metastatic sarcoma? |
| RS Benjamin |
|
JCO Jun 1 1987: 833–835.
[PDF]
|
|
| Coumarin plus cimetidine: yet another angle for therapy of renal cell carcinoma |
| JM Kirkwood and MS Ernstoff |
|
JCO Jun 1 1987: 836–837.
[PDF]
|
|
| Durable remissions in stage III follicular lymphoma: interpret with caution |
| SJ Horning |
|
JCO Jun 1 1987: 838–839.
[PDF]
|
|
|
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas |
| |
EC Borden, DA Amato, C Rosenbaum, HT Enterline, MJ Shiraki, RH Creech, HJ Lerner, and PP Carbone |
| |
JCO Jun 1 1987: 840–850.
[Abstract]
[PDF]
|
|
|
Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613) |
| |
LH Baker, J Frank, G Fine, SP Balcerzak, RL Stephens, WJ Stuckey, S Rivkin, J Saiki, and JH Ward |
| |
JCO Jun 1 1987: 851–861.
[Abstract]
[PDF]
|
|
|
Treatment of metastatic renal cell carcinoma with coumarin (1,2- benzopyrone) and cimetidine: a pilot study |
| |
ME Marshall, L Mendelsohn, K Butler, L Riley, J Cantrell, C Wiseman, R Taylor, and JS Macdonald |
| |
JCO Jun 1 1987: 862–866.
[Abstract]
[PDF]
|
|
|
Stage III follicular lymphoma: durable remissions with a combined chemotherapy-radiotherapy regimen |
| |
P McLaughlin, LM Fuller, WS Velasquez, JJ Butler, FB Hagemeister, JA Sullivan- Halley, and DO Dixon |
| |
JCO Jun 1 1987: 867–874.
[Abstract]
[PDF]
|
|
|
Patterns of disease in localized extranodal lymphomas |
| |
MK Gospodarowicz, SB Sutcliffe, TC Brown, T Chua, and RS Bush |
| |
JCO Jun 1 1987: 875–880.
[Abstract]
[PDF]
|
|
|
Treatment of metastatic breast cancer in premenopausal women using CAF with or without oophorectomy: an Eastern Cooperative Oncology Group Study |
| |
G Falkson, RS Gelman, DC Tormey, CI Falkson, JM Wolter, and FJ Cummings |
| |
JCO Jun 1 1987: 881–889.
[Abstract]
[PDF]
|
|
|
Colony formation in vitro as a prognostic indicator for primary breast cancer |
| |
MS Aapro, JF Eliason, F Krauer, and P Alberto |
| |
JCO Jun 1 1987: 890–896.
[Abstract]
[PDF]
|
|
|
Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma |
| |
DB Fuller, WT Sause, HP Plenk, and RL Menlove |
| |
JCO Jun 1 1987: 897–905.
[Abstract]
[PDF]
|
|
|
Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients |
| |
CJ Logothetis, DA Swanson, F Dexeus, C Chong, S Ogden, AG Ayala, AC von Eschenbach, DE Johnson, and ML Samuels |
| |
JCO Jun 1 1987: 906–911.
[Abstract]
[PDF]
|
|
|
Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer |
| |
FR Ahmann, DL Citrin, HA deHaan, P Guinan, VC Jordan, W Kreis, M Scott, and DL Trump |
| |
JCO Jun 1 1987: 912–917.
[Abstract]
[PDF]
|
|
|
Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide |
| |
MS Tallman, FR Appelbaum, D Amos, RS Goldberg, RB Livingston, J Mortimer, PL Weiden, and ED Thomas |
| |
JCO Jun 1 1987: 918–926.
[Abstract]
[PDF]
|
|
|
Cerebellar toxicity with high-dose cytosine arabinoside |
| |
RH Herzig, JD Hines, GP Herzig, SN Wolff, PA Cassileth, HM Lazarus, DJ Adelstein, RA Brown, PF Coccia, and S Strandjord |
| |
JCO Jun 1 1987: 927–932.
[Abstract]
[PDF]
|
|
|
Intellectual and academic achievement status after CNS relapse: a retrospective analysis of 40 children treated for acute lymphoblastic leukemia |
| |
RK Mulhern, J Ochs, D Fairclough, AL Wasserman, KS Davis, and JM Williams |
| |
JCO Jun 1 1987: 933–940.
[Abstract]
[PDF]
|
|
|
A phase II study of high-dose cisplatin and VP-16 in neuroblastoma: a report from the Societe Francaise d'Oncologie Pediatrique |
| |
T Philip, R Ghalie, R Pinkerton, JM Zucker, JL Bernard, G Leverger, and O Hartmann |
| |
JCO Jun 1 1987: 941–950.
[Abstract]
[PDF]
|
|
|
Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group |
| |
AP Venook, A Tseng, Jr, FJ Meyers, I Silverberg, R Boles, KK Fu, and CD Jacobs |
| |
JCO Jun 1 1987: 951–955.
[Abstract]
[PDF]
|
|
|
Controlled-release oral morphine sulfate in the treatment of cancer pain with pharmacokinetic correlation |
| |
A Khojasteh, W Evans, RD Reynolds, G Thomas, and JJ Savarese |
| |
JCO Jun 1 1987: 956–961.
[Abstract]
[PDF]
|
|
| Eligibility and extrapolation in cancer clinical trials |
| CB Begg and PF Engstrom |
|
JCO Jun 1 1987: 962–968.
[PDF]
|
|
|
Biliary tract obstruction secondary to cancer: management guidelines and selected literature review |
| |
JJ Lokich, RA Kane, DA Harrison, and WV McDermott |
| |
JCO Jun 1 1987: 969–981.
[Abstract]
[PDF]
|
|
| Adjuvant chemotherapy of osteosarcoma |
|
|
JCO Jun 1 1987: 982–984.
[PDF]
|
|
| Whither carboplatin |
|
|
JCO Jun 1 1987: 984–986.
[PDF]
|
|
| Inflammatory breast cancer |
| CJ Williams |
|
JCO Jun 1 1987: 986–987.
[PDF]
|
|
